The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease
NCT00046358 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2008-03-04
Summary
The purpose of this study is to determine whether short-term use of the drugs ibuprofen and lovastatin affects levels of a protein called beta-amyloid in people who are at risk for developing Alzheimer's Disease (AD).
Conditions
- Alzheimer Disease
Interventions
- DRUG
-
Lovostatin
- DRUG
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
lead NIH
Study Design
- Purpose
- TREATMENT
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-09-30
- Completion
- 2005-08-31
Countries
- United States
Study Locations
More Related Trials
-
BONSAI: Biomarkers of Nonsteroidal Anti-Inflammatories
NCT00239746 ·Status: UNKNOWN ·Phase: PHASE1
-
Statins, Cholesterol and Cognitive Decline in Alzheimer's
NCT06635252 ·Status: COMPLETED
-
Alzheimer's Disease: Potential Benefit of Isoflavones
NCT00205179 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) Patients
NCT00842920 ·Status: UNKNOWN ·Phase: PHASE4
-
Examining Neuroinflammation in AlzHeimer's
NCT03548883 ·Status: COMPLETED
-
Effects of an Anti-Inflammatory Drug in Alzheimer's Disease
NCT00013650 ·Status: COMPLETED ·Phase: PHASE1
-
Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs
NCT00065169 ·Status: COMPLETED ·Phase: NA
-
Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers
NCT04570644 ·Status: COMPLETED ·Phase: PHASE1
-
Mifepristone as Adjunctive Therapy in Alzheimer's Disease
NCT00105105 ·Status: TERMINATED ·Phase: PHASE2
-
The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease
NCT00548145 ·Status: TERMINATED ·Phase: NA
-
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
NCT04430517 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Bryostatin Treatment of Moderately Severe Alzheimer's Disease
NCT04538066 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment for Early Memory Loss
NCT00042172 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease
NCT01482013 ·Status: TERMINATED ·Phase: PHASE1
-
Brain Imaging in Alzheimer's Disease
NCT00039702 ·Status: COMPLETED
-
Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease
NCT04149860 ·Status: COMPLETED ·Phase: PHASE1
-
TNF-Alpha Inhibition for Treatment of Alzheimer's Disease
NCT00203359 ·Status: COMPLETED ·Phase: PHASE1
-
Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
NCT00053599 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers
NCT01005862 ·Status: COMPLETED ·Phase: PHASE1
-
SSRI's and the Rate of Progression From MCI to Dementia
NCT04901494 ·Status: WITHDRAWN
-
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
NCT06304883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
NCT02021682 ·Status: COMPLETED
-
Memory Impairment Study (Mild Cognitive Impairment Study)
NCT00000173 ·Status: COMPLETED ·Phase: PHASE3
-
A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)
NCT05551741 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Indomethacin on the Progression of Alzheimer's Disease
NCT00432081 ·Status: COMPLETED ·Phase: PHASE3